ACST

Acasti Pharma Inc (NASDAQ:ACST) has been struggling, as have most small bio caps stocks lately, but there are some signs of reversal in this downward path. What needs to be watched from here out is whether it is still being accumulated. The bounce off the recent sell-off lows could potentially be the start of an even higher move. The stock looks right on the brink of a breakout. It closed at $1.14 and I think any breakout would bring $1.65 and better into focus.